Healthcare provider profile · identity verified

Eric Aguinaldo, DO

Internal Medicine · BLUE ISLAND, IL · NPI 1720374002

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1015	313
Amlodipine Besylate	Amlodipine Besylate	576	181
Lisinopril	Lisinopril	377	94
Metformin Hcl	Metformin Hcl	377	100
Losartan Potassium	Losartan Potassium	345	102
Hydrochlorothiazide	Hydrochlorothiazide	286	94
Metoprolol Succinate	Metoprolol Succinate	284	99
Albuterol Sulfate Hfa	Albuterol Sulfate	271	91
Gabapentin	Gabapentin	265	107
Pantoprazole Sodium	Pantoprazole Sodium	222	71
Tamsulosin Hcl	Tamsulosin Hcl	186	53
Furosemide	Furosemide	184	56
Carvedilol	Carvedilol	171	46
Fluticasone Propionate	Fluticasone Propionate	151	54
Rosuvastatin Calcium	Rosuvastatin Calcium	147	46
Potassium Chloride	Potassium Chloride	146	44
Tramadol Hcl	Tramadol Hcl	139	46
Simvastatin	Simvastatin	137	35
Glipizide	Glipizide	134	44
Levothyroxine Sodium	Levothyroxine Sodium	134	42
Clopidogrel	Clopidogrel Bisulfate	122	32
Metoprolol Tartrate	Metoprolol Tartrate	120	34
Enalapril Maleate	Enalapril Maleate	118	32
Trulicity	Dulaglutide	114	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	27
Famotidine	Famotidine	106	36
Mirtazapine	Mirtazapine	101	36
Jardiance	Empagliflozin	99	32
Nifedipine Er	Nifedipine	97	30
Eliquis	Apixaban	95	33
Hydralazine Hcl	Hydralazine Hcl	94	32
Pravastatin Sodium	Pravastatin Sodium	93	28
Omeprazole	Omeprazole	89	28
Oxybutynin Chloride	Oxybutynin Chloride	79	29
Metformin Hcl Er	Metformin Hcl	77	27
Donepezil Hcl	Donepezil Hcl	67	14
Sertraline Hcl	Sertraline Hcl	63	20
Spironolactone	Spironolactone	59	22
Hydroxyzine Hcl	Hydroxyzine Hcl	57	23
Warfarin Sodium	Warfarin Sodium	56	12
Allopurinol	Allopurinol	54	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	34
Linzess	Linaclotide	50	18
Montelukast Sodium	Montelukast Sodium	50	15
Ibuprofen	Ibuprofen	49	24
Triamcinolone Acetonide	Triamcinolone Acetonide	49	25
Duloxetine Hcl	Duloxetine Hcl	48	22
Meclizine Hcl	Meclizine Hcl	48	19
Glipizide Er	Glipizide	47	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	15
Trazodone Hcl	Trazodone Hcl	43	17
Januvia	Sitagliptin Phosphate	39	12
Mounjaro	Tirzepatide	39	15
Meloxicam	Meloxicam	37	13
Sildenafil Citrate	Sildenafil Citrate	36	14
Finasteride	Finasteride	35	11
Glimepiride	Glimepiride	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	34	11
Alendronate Sodium	Alendronate Sodium	32	11
Naproxen	Naproxen	32	17
Xarelto	Rivaroxaban	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Baclofen	Baclofen	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Atenolol	Atenolol	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Azithromycin	Azithromycin	24	20
Ozempic	Semaglutide	24	suppressed
Torsemide	Torsemide	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Prednisone	Prednisone	23	16
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Promethazine Hcl	Promethazine Hcl	20	14
Colchicine	Colchicine	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	12
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Risperidone	Risperidone	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Ibu	Ibuprofen	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error